BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29949281)

  • 21. Over-diagnosis of hydatidiform mole in early tubal ectopic pregnancy.
    Burton JL; Lidbury EA; Gillespie AM; Tidy JA; Smith O; Lawry J; Hancock BW; Wells M
    Histopathology; 2001 May; 38(5):409-17. PubMed ID: 11422477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A clinicopathologic study of 153 cases of complete hydatidiform mole (1980-1990): histologic grade lacks prognostic significance.
    Genest DR; Laborde O; Berkowitz RS; Goldstein DP; Bernstein MR; Lage J
    Obstet Gynecol; 1991 Sep; 78(3 Pt 1):402-9. PubMed ID: 1876374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Term delivery of a complete hydatidiform mole with a coexisting living fetus followed by successful treatment of maternal metastatic gestational trophoblastic disease.
    Peng HH; Huang KG; Chueh HY; Adlan AS; Chang SD; Lee CL
    Taiwan J Obstet Gynecol; 2014 Sep; 53(3):397-400. PubMed ID: 25286799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregnancy outcome after hydatidiform mole, initial and recurrent.
    Yapar EG; Ayhan A; Ergeneli MH
    J Reprod Med; 1994 Apr; 39(4):297-9. PubMed ID: 8040847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
    Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
    Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repetitive complete and partial hydatidiform mole.
    Rice LW; Lage JM; Berkowitz RS; Goldstein DP; Bernstein MR
    Obstet Gynecol; 1989 Aug; 74(2):217-9. PubMed ID: 2748058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of TM4SF9 in human trophoblasts].
    Gao TY; Yu YH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1080-2. PubMed ID: 18583270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmenting effect of vitrification on lipid peroxidation in mouse preantral follicle during cultivation: Modulation by coenzyme Q
    Kashka RH; Zavareh S; Lashkarbolouki T
    Syst Biol Reprod Med; 2016 Dec; 62(6):404-414. PubMed ID: 27690645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteopontin is down-regulated in hydatidiform mole.
    Batorfi J; Fulop V; Kim JH; Genest DR; Doszpod J; Mok SC; Berkowitz RS
    Gynecol Oncol; 2003 Apr; 89(1):134-9. PubMed ID: 12694667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial recurrent hydatidiform mole: a review.
    Fisher RA; Hodges MD; Newlands ES
    J Reprod Med; 2004 Aug; 49(8):595-601. PubMed ID: 15457849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
    Hussein MR
    Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunohistochemistry of p57 and p53 protein in differential diagnosis of hydropic abortion, partial and complete hydatidiform mole].
    Chen YX; Shen DH; Gu YQ; Zhong PP; Xie JL; Song QJ; Zhang YL; Wen J
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):694-7. PubMed ID: 22321550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative proteomic analysis between benign and malignant-transformed hydatidiform mole.
    Ma L; Xiang Y; Zhao J; Feng F; Wan X
    J Reprod Med; 2008 Aug; 53(8):623-8. PubMed ID: 18773628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 11beta-Hydroxysteroid dehydrogenase activity in pregnancies complicated by hydatidiform mole.
    Muneyyrici-Delale O; Nacharaju VL; Sidell J; Neil G; Karacan M; Camilien L; Temkin S; Abulafia O
    Am J Reprod Immunol; 2006 Jun; 55(6):415-9. PubMed ID: 16674598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced expression of tissue inhibitor of metalloproteinase (TIMP)-2 in gestational trophoblastic diseases.
    Okamoto T; Niu R; Yamada S; Osawa M
    Mol Hum Reprod; 2002 Apr; 8(4):392-8. PubMed ID: 11912288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
    Niemann I; Hansen ES; Sunde L
    Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?
    Earp KE; Hancock BW; Short D; Harvey RA; Fisher RA; Drew D; Sarwar N; Tidy JA; Winter MC; Chien P; Seckl MJ
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():117-119. PubMed ID: 30684876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gestational trophoblastic disease within an elective abortion population.
    Cohen BA; Burkman RT; Rosenshein NB; Atienza MF; King TM; Parmley TH
    Am J Obstet Gynecol; 1979 Oct; 135(4):452-4. PubMed ID: 484643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accelerated atherosclerosis in haemodialysis patients; correlation of endothelial function with oxidative DNA damage.
    Kaya Y; Ari E; Demir H; Soylemez N; Cebi A; Alp H; Bakan E; Gecit I; Asicioglu E; Beytur A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1164-9. PubMed ID: 21821836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.